Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10060311HBVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS30087023HIVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS30074133HIVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20007384HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20007385HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20004195HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20065658HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20043075HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20024956HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20034877HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TCGA Plot Options
Drug Information
GeneINSR
DrugBank IDDB00046
Drug NameInsulin lispro
Target IDBE0000033
UniProt IDP06213
Regulation Typeagonist
PubMed IDs11752352; 8964871; 8937933; 20424816; 27512793
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Jehle PM, Fussgaenger RD, Kunze U, Dolderer M, Warchol W, Koop I: The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab. 1996 Jun;81(6):2319-27.@@Jehle PM, Fussganger RD, Seibold A, Luttke B, Bohm BO: Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus. Int J Clin Pharmacol Ther. 1996 Nov;34(11):498-503.@@Sciacca L, Cassarino MF, Genua M, Pandini G, Le Moli R, Squatrito S, Vigneri R: Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia. 2010 Aug;53(8):1743-53. doi: 10.1007/s00125-010-1760-6. Epub 2010 Apr 28.@@De Meyts P: The Insulin Receptor and Its Signal Transduction Network .
GroupsApproved
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164747059
ChEMBLCHEMBL1201538